Skip to main content
An official website of the United States government

Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer

Major Program
Phase 0 I II Cancer Prevention Clinical Trials Program
Research Group
Breast and Gynecologic Cancer
Chemopreventive Agent Development
Sponsor
National Cancer Institute (NCI)
Status
Completed
NCT ID
NCT00290758
This randomized phase II trial is studying how well genistein works in preventing breast cancer in women at high risk for breast cancer. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of genistein may prevent breast cancer in women at high risk for breast cancer.
Intervention
genistein, laboratory biomarker analysis, placebo
Condition
Breast Cancer
Investigators
Seema Khan

See list of participating sites